In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Microscopy image of vancomycin-resistant Enterococcus
In the Lab
Researchers Identify a Bacterial Species That Could Protect against Hospital-Acquired Infections

MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.
Mehmet Erman Karasu
Announcement
2019 GSK Chairman’s Prize Lauds Research to Better Understand Reproductive-Cell-Division Process

Learn about the work of Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2019 Chairman’s Prize.
An illustration of two teapots with liquid flowing into various cups
In the Lab
How Stem Cells Decide Their Fate

Research in blood stem cells has revealed new information about how these cells decide what to become when they divide.
An illustration of proteins serving as bar-code-reading drones
In the Lab
“Molecular Origami” Enables Proteins to Serve as Specialized Delivery Vehicles, Study Finds

Scientists at the Sloan Kettering Institute have identified a fundamentally new type of protein-sorting system in cells.
Cancer biologist and pediatric oncologist Alex Kentsis
In the Lab
Analyzing Urine Can Guide the Treatment of Childhood Kidney Tumors

A protein detected in the urine of children with Wilms’ tumor led to the development of a test to improve diagnosis and treatment.
New Study Examines Wilms’ Tumor Relapse and May Give Clues to about Which Other Childhood Cancers Could Relapse

Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance.
An illustration of sugar pouring onto NRF2
Finding
Sugar Directly Controls a Cancer-Causing Protein, Scientists Find

The discovery suggests a potential new treatment approach for certain cancers.
Medical oncologist William Tap
In the Clinic
FDA Approves Pexidartinib, a Targeted Therapy for a Tumor of the Joints

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.
woman with shaved head in mirror
How to Regain Body Confidence after Cancer

Hear from an MSK social worker about developing body confidence after cancer treatment.
MSK surgeons are highly skilled at treating even the most difficult gynecologic cancers.
In the Clinic
5 Reasons MSK Excels at Treating Gynecologic Cancers

Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.